60 Degrees Pharmaceuticals to Participate in H.C. Wainwright 25th Annual Global Investment Conference
06 Settembre 2023 - 1:31PM
60 Degrees Pharmaceuticals Inc. (“60P” or the “Company”) (Nasdaq:
SXTP), a pharmaceutical company focused on developing new medicines
for infectious diseases, announced today that CEO Dr. Geoff Dow and
CFO Ty Miller will participate in the H.C. Wainwright 25th Annual
Global Investment Conference September 11-13, to be held in
New York City.
A 20-minute, pre-recorded
management investor presentation will be available on demand here
starting Monday September 11, 2023, 7:00 AM eastern time.
Participants will be able to submit questions for management at
that time through the webcast link.
Attendees interested in 1 x 1 meetings with Dr. Dow and Mr.
Miller are invited to request them through the conference’s meeting
scheduler at meetings@hcwco.com or by calling or emailing the
investor contact below.
A replay of the investor
presentation will be available on 60P’s investor
relations site for 30 days following the event.
About 60 Degrees Pharmaceuticals, Inc.60
Degrees Pharmaceuticals, Inc., founded in 2010, specializes in
developing and marketing new medicines for the treatment and
prevention of infectious diseases that affect the lives of millions
of people. 60P achieved FDA approval of its lead product, ARAKODA®
(tafenoquine), for malaria prevention, in 2018. 60P also
collaborates with prominent research organizations in the U.S.,
Australia and Singapore. 60P’s mission has been supported through
in-kind funding from the United States Department of Defense and
private institutional investors including Knight Therapeutics Inc.,
a Canadian-based pan-American specialty pharmaceutical company. 60P
is headquartered in Washington D.C., with a majority-owned
subsidiary in Australia. Learn more at www.60degreespharma.com.
Media Contact: |
Investor Contact: |
Sheila A. Burke |
Patrick Gaynes |
SheilaBurke-consultant@60degreesPharma.com |
patrickgaynes@60degreespharma.com |
(484) 667-6330 |
(310) 989-5666 |
Grafico Azioni 60 Degrees Pharmaceuticals (NASDAQ:SXTP)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni 60 Degrees Pharmaceuticals (NASDAQ:SXTP)
Storico
Da Giu 2023 a Giu 2024